August 30, 2026
Sunday, August 30, 2026
This week: 8 trending tweets, 8 new studies.
New Research
Drug failure in diabetic kidney disease: translational barriers, target validation and trial de-risking strategies.
Biochemical pharmacology
GLP-1 and GIP class drugs have neuroprotective properties in Alzheimer's and Parkinson's disease.
Frontiers in neuroscience
Medical nutrition therapy in incretin-treated obesity-related heart failure with preserved ejection fraction.
Frontiers in nutrition
Clinical efficacy of tirzepatide for weight regain and suboptimal glycemic control following laparoscopic sleeve gastrectomy: a case series of three patients with obesity-associated type 2 diabetes.
Frontiers in endocrinology
Incretin-based therapies in peri- and postmenopausal women with obesity: an expert position statement from the Spanish Menopause Society.
Maturitas
Discontinuation of Semaglutide Therapy for Obesity Management.
JAMA network open
The liver-gut-brain axis in metabolic dysfunction-associated steatotic liver disease: bidirectional communication, clinical implications, and future perspectives.
Frontiers in endocrinology
The menopause-obesity axis in MASH progression: from estrogen decline to liver fibrosis.
Frontiers in gastroenterology (Lausanne, Switzerland)
Trending on X
The Peptide super cycle covered on Substack below 💉💊 https://t.co/LpvPjWuuAp What are peptides? Peptides are short chains of amino acids linked together by chemical bonds. You can think of them as smaller, simpler versions of proteins. Peptides are experiencing a massive
RT @DailyPeptide: Peptides ranked by category (fight me): 🔥 fat loss 1.Retatrutide 2.Tirzepatide 3.Semaglutide 💪 recovery 1.BPC-157 2.TB-…
some quick thoughts on the benefit-risk profile of giving peptides to your dog, especially BPC-157 for osteoarthritis https://t.co/4u0mc4FUaL
Peptide craze has hit the market. BPC-157, TB-500, GHK-Cu, Semax, Epithalon and more. Don’t tap “I agree” like it’s an app login while you consent to peptide therapy. There are reasons why FDA has not approved any of these peptides. Know these risks. 1. Possible cancer risk
Dismissing peptides as pseudoscience is an uninformed take Insulin is a peptide and it’s FDA-approved Thymosin Alpha-1 is a peptide and it’s approved in 35+ countries Cerebrolysin is a peptide and it’s approved in India and many other countries GH is essentially a peptide and
I explore both sides of the argument and some uncomfortable truths about the peptide industry... https://t.co/dMtsU9J803
@sowmay_jain In India, peptides are regulated as prescription drugs under the Drugs and Cosmetics Act, 1940 and Rules, 1945, overseen by the CDSCO. Approved peptide medications (such as GLP-1 analogs like semaglutide for diabetes or obesity) require a valid prescription from a registered
let me just list a bunch of peptide and see if the algorithm catches on GHK-CU BPC-157 TB-500 Retatrutide Tirzepatide Semaglutide CJC-1295 NAD+ Hot Pockets Dominos Wendys Pizza Hut McDonalds Shark Tank https://t.co/03po51Yy7d
Provider Spotlight
MEDVi
MEDvidi is an online mental health treatment center specializing in personalized, affordable telehealth services for conditions such as anxiety, ADHD, depression, and insomnia. They offer compassionate care from licensed medical professionals with a fully digital, human-centered approach.